Filter News
Area of Research
- Advanced Manufacturing (2)
- Biological Systems (1)
- Biology and Environment (17)
- Clean Energy (14)
- Computational Biology (1)
- Computational Engineering (1)
- Fusion and Fission (1)
- Isotopes (4)
- Materials (31)
- Materials for Computing (5)
- National Security (6)
- Neutron Science (73)
- Nuclear Science and Technology (3)
- Supercomputing (21)
News Type
News Topics
- (-) Biomedical (46)
- (-) Neutron Science (96)
- 3-D Printing/Advanced Manufacturing (85)
- Advanced Reactors (18)
- Artificial Intelligence (78)
- Big Data (34)
- Bioenergy (74)
- Biology (81)
- Biotechnology (18)
- Buildings (31)
- Chemical Sciences (53)
- Clean Water (16)
- Climate Change (72)
- Composites (17)
- Computer Science (144)
- Coronavirus (34)
- Critical Materials (15)
- Cybersecurity (31)
- Decarbonization (64)
- Education (4)
- Element Discovery (1)
- Emergency (2)
- Energy Storage (70)
- Environment (139)
- Exascale Computing (36)
- Fossil Energy (5)
- Frontier (40)
- Fusion (44)
- Grid (40)
- High-Performance Computing (73)
- Hydropower (5)
- Isotopes (45)
- ITER (4)
- Machine Learning (35)
- Materials (100)
- Materials Science (95)
- Mathematics (7)
- Mercury (9)
- Microelectronics (3)
- Microscopy (36)
- Molten Salt (3)
- Nanotechnology (42)
- National Security (57)
- Net Zero (11)
- Nuclear Energy (81)
- Partnerships (45)
- Physics (53)
- Polymers (20)
- Quantum Computing (30)
- Quantum Science (56)
- Renewable Energy (2)
- Security (22)
- Simulation (40)
- Software (1)
- Space Exploration (15)
- Statistics (2)
- Summit (52)
- Sustainable Energy (77)
- Transformational Challenge Reactor (7)
- Transportation (52)
Media Contacts
OAK RIDGE, Tenn., March 20, 2019—Direct observations of the structure and catalytic mechanism of a prototypical kinase enzyme—protein kinase A or PKA—will provide researchers and drug developers with significantly enhanced abilities to understand and treat fatal diseases and neurological disorders such as cancer, diabetes, and cystic fibrosis.
OAK RIDGE, Tenn., March 4, 2019—A team of researchers from the Department of Energy’s Oak Ridge National Laboratory Health Data Sciences Institute have harnessed the power of artificial intelligence to better match cancer patients with clinical trials.
While studying the genes in poplar trees that control callus formation, scientists at Oak Ridge National Laboratory have uncovered genetic networks at the root of tumor formation in several human cancers.
A team of scientists has for the first time measured the elusive weak interaction between protons and neutrons in the nucleus of an atom. They had chosen the simplest nucleus consisting of one neutron and one proton for the study.
The Spallation Neutron Source at the Department of Energy’s Oak Ridge National Laboratory has broken a new record by ending its first neutron production cycle in fiscal year 2019 at its design power level of 1.4 megawatts.
Scientists at the Department of Energy’s Oak Ridge National Laboratory used neutrons, isotopes and simulations to “see” the atomic structure of a saturated solution and found evidence supporting one of two competing hypotheses about how ions come
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.
“Made in the USA.” That can now be said of the radioactive isotope molybdenum-99 (Mo-99), last made in the United States in the late 1980s. Its short-lived decay product, technetium-99m (Tc-99m), is the most widely used radioisotope in medical diagnostic imaging. Tc-99m is best known ...
After more than a year of operation at the Department of Energy’s (DOE’s) Oak Ridge National Laboratory (ORNL), the COHERENT experiment, using the world’s smallest neutrino detector, has found a big fingerprint of the elusive, electrically neutral particles that interact only weakly with matter.
Researchers used neutrons to probe a running engine at ORNL’s Spallation Neutron Source